(Q46500081)

22 December 2017

title

Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97. (English)

1 reference

22 December 2017

Mycobacterium tuberculosis

main subject

South Africa

0 references

1 reference

1 reference

1 reference

Mycobacterium vaccae

1 reference

Mayo RE

1

1 reference

22 December 2017

Stanford JL

series ordinal

2

1 reference

22 December 2017

publication date

1 September 2000

1 reference

22 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

22 December 2017

volume

94

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

563-568

1 reference

22 December 2017

A trial of antigen marianum as an adjunct of D.D.S. in the treatment of lepromatous leprosy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Consortium aims to kick-start TB research

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy for drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172)

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

The pathogenesis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Strengthening "DOTS" through community care for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

WHO identifies 16 countries struggling to control tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990088-9

7 January 2021

10.1016/S0035-9203(00)90088-9

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017